Table 1 Stage and grade distribution of bladder cancer in our study patients
From: ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
Patients groups and subgroupsa | Ib(n = 43) | II (n = 6) |
|---|---|---|
IA (n = 29)/IB (n = 14) | ||
Number of cases per group | ||
Stage | ||
Ta | 18 (41.9%) | - |
14 (48.3%)/4 (28.5%) | ||
T1 | 25 (58.1%) | - |
15 (51.7%)/10 (71.4%) | ||
T2 | - | 6 (100%) |
Stage/grade | ||
TaG1c | 12 (27.9%) | - |
9 (31.0%)/4 (28.5%) | ||
TaG2 | 6 (13.9%) | - |
5 (17.2%)/-(0%) | ||
T1G1 | 6 (13.9%) | |
5 (17.2%)/1 (7.1%) | ||
T1G2 | 14 (32.6%) | |
7 (24.1%)/7 (50.0%) | ||
T1G3 | 5 (11.6%) | |
3 (10.3%)/2 (14.3%) | ||
T2G2 | - | 3 (50%) |
T2G3 | - | 3 (50%) |